Compare ADXN & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADXN | FGI |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 14.0M |
| IPO Year | N/A | 2022 |
| Metric | ADXN | FGI |
|---|---|---|
| Price | $7.47 | $6.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 76.8K |
| Earning Date | 12-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $198,824.00 | ★ $135,654,095.00 |
| Revenue This Year | $86.57 | $3.80 |
| Revenue Next Year | N/A | $6.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.66 |
| 52 Week Low | $6.51 | $2.28 |
| 52 Week High | $12.05 | $12.62 |
| Indicator | ADXN | FGI |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 51.75 |
| Support Level | $7.01 | $5.51 |
| Resistance Level | $8.30 | $7.18 |
| Average True Range (ATR) | 0.42 | 1.42 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 23.23 | 29.47 |
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.